跳至主要内容
临床试验/ITMCTR1900002834
ITMCTR1900002834招募中4 期

Clinical study on improving postoperative symptoms of cervical spondylotic myelopathy by Qishe pill

onghua Hospital Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria;
  • 2. The patients were aged between 18 and 80 years.
  • 3. Cervical spondylotic myelopathy patients receiving surgical treatment (including anterior and posterior);
  • 4. Signed Informed consent.

排除标准

  • 1. Women who are nursing or preparing for pregnancy;
  • 2. Patients with liver, kidney, hematopoietic system, endocrine system and other serious primary diseases and mental diseases;
  • 3. Patients with other spinal diseases, tumors, cerebral infarction, etc. that affect limb sensation and function;
  • 4. A suspected history of alcohol or drug abuse, or, in judgment, a reduced likelihood of inclusion or admission;
  • 5. Subjects who are participating in other drug clinical studies.

研究者

发起方
onghua Hospital Shanghai University of Traditional Chinese Medicine

相似试验